Mr. Blatchley's practice focuses on securities fraud litigation. He is currently a member of the firm's new matter department in which he, along with a team of attorneys, financial analysts, forensic accountants, and investigators, counsels the firm's clients on their legal claims.
Mr. Blatchley has also served as a member of the litigation teams responsible for prosecuting a number of the firm's significant cases. Most recently, he was a senior member of the team prosecuting In re Allergan, Inc. Proxy Violations Securities Litigation, which settled for $250 million and is now pending Court approval. He was also a key member of the team that recovered $150 million for investors in In re JPMorgan Chase & Co. Securities Litigation, a securities fraud class action arising out of misrepresentations and omissions concerning JPMorgan's Chief Investment Office, the company's risk management systems, and the trading activities of the so-called "London Whale."
Mr. Blatchley was also a member of the litigation team in In re Medtronic, Inc. Securities Litigation, an action arising out of allegations that Medtronic promoted the Infuse bone graft for dangerous "off-label" uses, which resulted in an $85 million recovery for investors. In addition, he prosecuted a number of cases related to the financial crisis, including several actions arising out of wrongdoing related to the issuance of residential mortgage-backed securities and other complex financial products.
While attending Brooklyn Law School, Mr. Blatchley held a judicial internship position for the Honorable David G. Trager, United States District Judge for the Eastern District of New York. In addition, he worked as an intern at The Legal Aid Society's Harlem Community Law Office, as well as at Brooklyn Law School's Second Look and Workers' Rights Clinics, and provided legal assistance to victims of Hurricane Katrina in New Orleans, Louisiana.
Last updated: July 2018